Loss of PTEN expression in ERG-negative prostate cancer predicts secondary therapies and leads to shorter disease-specific survival time after radical prostatectomy
出版年份 2016 全文链接
标题
Loss of PTEN expression in ERG-negative prostate cancer predicts secondary therapies and leads to shorter disease-specific survival time after radical prostatectomy
作者
关键词
-
出版物
MODERN PATHOLOGY
Volume 29, Issue 12, Pages 1565-1574
出版商
Springer Nature
发表日期
2016-08-26
DOI
10.1038/modpathol.2016.154
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Prostate Cancer Grading
- (2016) Jonathan I. Epstein AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Deletion of Interstitial Genes betweenTMPRSS2andERGPromotes Prostate Cancer Progression
- (2016) Douglas E. Linn et al. CANCER RESEARCH
- Identification of Combinatorial Genomic Abnormalities Associated with Prostate Cancer Early Recurrence
- (2016) Xiaoyu Qu et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Improvements in Radiographic Progression-Free Survival Stratified by ERG Gene Status in Metastatic Castration-Resistant Prostate Cancer Patients Treated with Abiraterone Acetate
- (2015) G. Attard et al. CLINICAL CANCER RESEARCH
- Genomic Predictors of Outcome in Prostate Cancer
- (2015) Peter J. Boström et al. EUROPEAN UROLOGY
- Heterogeneity of PTEN and ERG expression in prostate cancer on core needle biopsies: implications for cancer risk stratification and biomarker sampling
- (2015) Rajal B. Shah et al. HUMAN PATHOLOGY
- TheTMPRSS2:ERGfusion and response to androgen deprivation therapy for prostate cancer
- (2015) Rebecca E. Graff et al. PROSTATE
- The prognostic significance of combined ERG and androgen receptor expression in patients with prostate cancer managed by androgen deprivation therapy
- (2014) Kuo-Cheng Huang et al. CANCER BIOLOGY & THERAPY
- Tissue Biomarkers for Prognosis of Prostate Cancer: A Systematic Review and Meta-analysis
- (2014) L. Zhao et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Recurrent Prostate Cancer Genomic Alterations Predict Response to Brachytherapy Treatment
- (2014) J. Fontugne et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- PTEN loss in biopsy tissue predicts poor clinical outcomes in prostate cancer
- (2014) Prabhakar Mithal et al. INTERNATIONAL JOURNAL OF UROLOGY
- Heterogeneity and chronology of PTEN deletion and ERG fusion in prostate cancer
- (2014) Antje Krohn et al. MODERN PATHOLOGY
- Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer
- (2013) J Cuzick et al. BRITISH JOURNAL OF CANCER
- Loss of PTEN Is Associated with Aggressive Behavior in ERG-Positive Prostate Cancer
- (2013) K. A. Leinonen et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Genetic Profiling to Determine Risk of Relapse-Free Survival in High-Risk Localized Prostate Cancer
- (2013) Christine M. Barnett et al. CLINICAL CANCER RESEARCH
- ETV1 directs androgen metabolism and confers aggressive prostate cancer in targeted mice and patients
- (2013) E. Baena et al. GENES & DEVELOPMENT
- The prognostic role of ERG immunopositivity in prostatic acinar adenocarcinoma: a study including 454 cases and review of the literature
- (2013) Bin Xu et al. HUMAN PATHOLOGY
- Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma
- (2013) Leilei Chen et al. NATURE MEDICINE
- Assessing the order of critical alterations in prostate cancer development and progression by IHC: further evidence that PTEN loss occurs subsequent to ERG gene fusion
- (2013) B Gumuskaya et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Genomic Deletion of PTEN Is Associated with Tumor Progression and Early PSA Recurrence in ERG Fusion-Positive and Fusion-Negative Prostate Cancer
- (2012) Antje Krohn et al. AMERICAN JOURNAL OF PATHOLOGY
- The TMPRSS2:ERG Rearrangement, ERG Expression, and Prostate Cancer Outcomes: A Cohort Study and Meta-analysis
- (2012) A. Pettersson et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Clonal Progression of Prostate Cancers from Gleason Grade 3 to Grade 4
- (2012) A. G. Sowalsky et al. CANCER RESEARCH
- International Variation in Prostate Cancer Incidence and Mortality Rates
- (2012) Melissa M. Center et al. EUROPEAN UROLOGY
- Nuclear Stat5a/b predicts early recurrence and prostate cancer–specific death in patients treated by radical prostatectomy
- (2012) Tuomas Mirtti et al. HUMAN PATHOLOGY
- Cysteine-rich secretory protein 3 overexpression is linked to a subset of PTEN-deleted ERG fusion-positive prostate cancers with early biochemical recurrence
- (2012) Katharina Grupp et al. MODERN PATHOLOGY
- Loss of PTEN expression is associated with increased risk of recurrence after prostatectomy for clinically localized prostate cancer
- (2012) Alcides Chaux et al. MODERN PATHOLOGY
- PTEN Protein Loss by Immunostaining: Analytic Validation and Prognostic Indicator for a High Risk Surgical Cohort of Prostate Cancer Patients
- (2011) T. L. Lotan et al. CLINICAL CANCER RESEARCH
- ERG Status Is Unrelated to PSA Recurrence in Radically Operated Prostate Cancer in the Absence of Antihormonal Therapy
- (2011) Sarah Minner et al. CLINICAL CANCER RESEARCH
- Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer
- (2011) Biswajyoti Sahu et al. EMBO JOURNAL
- ERG immunohistochemistry is not predictive for PSA recurrence, local recurrence or overall survival after radical prostatectomy for prostate cancer
- (2011) A Marije Hoogland et al. MODERN PATHOLOGY
- Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer
- (2010) A H M Reid et al. BRITISH JOURNAL OF CANCER
- An Update of the Gleason Grading System
- (2009) Jonathan I. Epstein JOURNAL OF UROLOGY
- Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression
- (2009) Bo Han et al. MODERN PATHOLOGY
- Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate
- (2009) Brett S Carver et al. NATURE GENETICS
- Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome
- (2008) Maisa Yoshimoto et al. MODERN PATHOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now